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Abstract
Biologically active metal ions in low doses have the potential to accelerate bone defect heal-
ing. For successful remodelling the interaction of bone graft materials with both bone-form-
ing osteoblasts and bone resorbing osteoclasts is crucial. In the present study brushite
forming calcium phosphate cements (CPC) were doped with Co2+, Cu2+ and Cr3+ and the
influence of these materials on osteoclast differentiation and activity was examined. Human
osteoclasts were differentiated from human peripheral blood mononuclear cells (PBMC)
both on the surface and in indirect contact to the materials on dentin discs. Release of cal-
cium, phosphate and bioactive metal ions was determined using ICP-MS both in the pres-
ence and absence of the cells. While Co2+ and Cu2+ showed a burst release, Cr3+ was
released steadily at very low concentrations (below 1 μM) and both calcium and phosphate
release of the cements was considerably changed in the Cr3+ modified samples. Direct culti-
vation of PBMC/osteoclasts on Co2+ cements showed lower attached cell number com-
pared to the reference but high activity of osteoclast specific enzymes tartrate resistant acid
phosphatase (TRAP), carbonic anhydrase II (CAII) and cathepsin K (CTSK) and signifi-
cantly increased gene expression of vitronectin receptor. Indirect cultivation with diluted
Co2+ cement extracts revealed highest resorbed area compared to all other modifications
and the reference. Cu2+ cements had cytotoxic effect on PBMC/osteoclasts during direct
cultivation, while indirect cultivation with diluted extracts from Cu2+ cements did not pro-
voke cytotoxic effects but a strictly inhibited resorption. Cr3+ doped cements did not show
cytotoxic effects at all. Gene expression and enzyme activity of CTSK was significantly
increased in direct culture. Indirect cultivation with Cr3+ doped cements revealed signifi-
cantly higher resorbed area compared to the reference. In conclusion Cr3+ doped calcium
phosphate cements are an innovative cement modification because of their high cytocom-
patibility and support of active resorption by osteoclasts.
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Introduction
The development of synthetic calcium phosphate based bone graft materials includes the incorpo-
ration of bioactive molecules, like growth factors and drugs to generate osteoinductive properties.
Besides organic components, metal ions in low doses are increasingly applied for the modification
of bone graft materials to improve osteogenesis and neovascularization [1–3]. Co2+ doping of cal-
cium phosphate was shown to have proangiogenic effects [4,5]. Cu2+ modification of a calcium
phosphate ceramic resulted in an enhanced and directed vascularization [6]. In a previous study
we have analyzed the impact of Co2+, Cu2+ and Cr3+ doping of biomimetic calcium phosphate
bone cement on materials properties, as well as on proliferation and osteogenic differentiation of
human mesenchymal stromal cells in vitro [7]. A positive effect of doping with Cr3+ and, to a less
extend, of Cu2+ on proliferation and osteogenic differentiation was found.
However, examinations for in vitro osteogenic capacity of potential bone graft materials are
not sufficient to estimate clinical performance. Since the balance between new bone formation
and resorption of the materials is crucial for successful remodeling, the in vitro analysis of oste-
oclast-mediated degradation of the materials is a logical next step to evaluate remodeling of
the materials in vivo. Brushite forming calcium phosphate bone cements show a higher chemi-
cal dissolution rate compared to hydroxyapatite (HA) forming calcium phosphate bone
cements [8]. Nevertheless, active resorption of these materials is important to enable remodel-
ing, especially due to the phase conversion of brushite to HA at neutral pH [9].
The effect of Co2+ and Cr3+ ions on osteoclast formation and resorption activity is in the
focus of interest, since both ions are applied in prosthetic implant alloys. Co2+ and Cr3+ are
released from wear particles after metal-on-metal joint arthroplasty and the concentration of
these ions is elevated in serum and urine of the respective patients [10,11]. It was shown, that
metallic wear particles from cobalt-chromium alloys induce the formation of multinucleated
giant cells [12]. Co2+ and Cr3+ ions released from wear debris are suspected to promote aseptic
loosening and osteolysis [13]. Andrews and co-workers examined the influence of Co2+ and
Cr3+ ions on osteoclast formation and resorption activity and found both stimulatory and
inhibitory effect of these ions, depending on the concentration [14]. The effect of Cu2+ ions
incorporated in calcium phosphate films was studied with primary rat osteoclasts and a signifi-
cantly reduced resorptive activity was reported [15].
Cell-based in vitro resorption assays are an important tool to simulate the in vivo biodegra-
dation of resorbable bone graft materials to estimate their clinical performance [16]. In a
recently published paper we analyzed the significance of osteoclast specific enzyme activities tar-
trate resistant acid phosphatase (TRAP), carbonic anhydrase II (CAII) and cathepsin K (CTSK)
for the evaluation of resorption [17]. The central finding was that the correlation between osteo-
clast-related enzyme activities and resorption is dependent on the resorbed material. It was pos-
tulated, that resorption of inorganic calcium phosphate materials is reflected by the intracellular
TRAP and CAII activity, while in the case of collagen containing materials like dentin and min-
eralized collagen the extracellular TRAP and CTSK activity correlates to the resorbed area [17].
Brushite forming calcium phosphate bone cements display a rough surface [7] and therefore the
discrimination between resorption pits and structural irregularities is not possible both on the
non-modified brushite cement and the metal ion doped modifications. The experimental setup
of the present study involves therefore 1) the direct cultivation of osteoclasts, derived from
human peripheral blood mononuclear cells (PBMC) on the different cement modifications and
the analysis of the osteoclast specific enzyme activities of TRAP and CAII and the mRNA
expression of osteoclast markers and 2) the cultivation of osteoclasts on TCPS and dentin slices
in the presence of cement extracts to evaluate the influence of the cement modifications on the
resorption activity by classical pit assays and TRAP staining. Furthermore, the passive and
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active, osteoclast-mediated release of Ca2+, PO4
3- and Cr3+ from the cement was examined to
analyse the resorption of the Cr3+ modified cements.
The aim of the study was to analyse the influence of doping with bioactive metal ions on
osteoclastic resorption of calcium phosphate bone cement.
Materials and methods
Cement preparation
Brushite-forming calcium phosphate cements modified with low doses of Cu2+, Co2+ and Cr3+
were prepared as described previously [7]. Briefly, dicalcium phosphate anhydrous (DCPA,
Baker, Germany) and calcium carbonate (CC, Merck, Germany) were mixed with metal
nitrates (Cu(NO3)23 H2O; Co(NO3)26 H2O; Cr(NO3)39 H2O, Aldrich) in an appropriate
stoichiometric ratio. The powder mixtures were sintered at 1050˚C for 5 h resulting in metal
ion doped ß-TCP with a metal ion concentration of 10 and 100 mmol per mol β-TCP. The sin-
tered cakes were crushed and sieved with 100 μm pore size-mesh followed by ball milling for
60 min at 200 rpm. Brushite cements were produced by mixing the β-TCP powder in a molar
ratio of 1:0.8 with anhydrous monocalcium phosphate (Ca(H2PO4)2, MCPA, Aldrich) for 30 s.
For the modification with 50 mmol Cr3+ per g β-TCP samples of β-TCP powder doped with
100 mmol Cr3+ were mixed in an equimolar ratio with pure β-TCP powder. An aqueous solu-
tion of 0.1 M phytic acid (Aldrich) was used as setting retarder as liquid cement phase in a
powder to liquid ratio of 2 g/ml. The cement pastes were then transferred into silicon moulds
with 6 mm diameter and stored in a water bath with 100% relative humidity and 37˚C for 24
h. The following cement modifications were included into this study: 10 mmol Cu2+/g β-TCP
(“Cu10”), 10 mmol Co2+/g β-TCP (“Co10”), 10 mmol Cr3+/g β-TCP (“Cr10”), 50 mmol Cr3+/g
β-TCP (“Cr50”) Furthermore, cement without metal ions was prepared as a reference. Prior to
use in cell culture experiments, the cement samples were sterilized by γ-irradiation.
Quantification of ions released by the cements
Ion concentrations (Ca2+, P as PO4
3-, Cr3+) in the cell culture supernatants and in cement
extracts were determined using inductively-coupled-plasma mass-spectrometry (ICP-MS,
Varian, Germany). The quantitative measurement was carried out against standard solutions
(Merck) containing defined concentrations of all ions of interest.
Preparation of cement extracts
Cement discs were incubated in α-MEM containing 5% heat-inactivated FCS, 5% human A/B
serum (Sigma), 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine for 3 weeks. Me-
dium was changed twice weekly and the collected extracts were combined for each cement mo-
dification. Concentration of Cu2+, Co2+, and Cr3+ in the combined fraction was analysed by ICP
(see above) and were as follows: Cu10: 11286 +/- 311 μg/l (177.6 μM); Co10: 11809 +/- 411 μg/l
(200.4 μM), Cr10: 77 +/- 4 μg/l (1.48 μM), Cr50: 160 +/- 5 μg/l (3.08 μM). Before applying the
cement extracts to cell culture the extracts from the Cu10 and Co10 cements were diluted 1: 10
with medium, resulting in Co2+ concentration of 20.0 μM and a Cu2+ concentration of 17.8 μM.
Osteoclast formation
Peripheral blood mononuclear cells (PBMC) were differentiated into osteoclasts under stimu-
lation with macrophage colony stimulating factor (MCSF) and Receptor Activator of NF-κB
Ligand (RANKL). PBMC were isolated from human buffy coats, purchased from the German
Red Cross Dresden, as described previously [18]. Briefly, PBMC were separated by density
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gradient centrifugation (Ficoll Paque Plus), and remaining erythrocytes were lysed with de-
ionized water for 1 min. Composition of PBMC fraction (containing T-lymphocytes, B- cells
and monocytes) was evaluated with an automated cell counter (Scepter, Millipore). Cement
discs (6 mm diameter, 1 mm height, sterilized by γ-irradiation and pre-incubated in 1 ml of α-
MEM containing 10% heat-inactivated FCS overnight) were seeded with PBMC containing
2105 monocytes per sample. For indirect cultivation with cements extracts, PBMC containing
4105 monocytes were seeded on dentin discs of 0.8 mm thickness, which have been cut from
canine teeth of minipigs [17] in 48-well tissue culture polystyrene (TCPS) plates. Furthermore,
48-well TCPS plates were seeded with PBMC containing 1105 monocytes. Direct cultivation
of PBMC/osteoclasts on the cements was repeated in four independent experiments: three
experiments were performed with PBMC of two donors each, and one experiment with PBMC
of three donors. Since only the reference and Cr10 cement were included in all four experi-
ments, the total number of biochemical data included cells of 9 donors (45 individual samples)
each for reference and Cr10, cells of 6 donors (30 individual samples) each for Cu10 and Co10
modification and cells of 5 donors (25 individual samples) for Cr50 modification, since all bio-
chemical examinations were done in pentaplicates. Additional samples were prepared for
microscopic and gene expression analysis. For indirect cultivation with cement extracts cells of
three donors were used in pentaplicates on TCPS (15 individual samples per modification)
and in duplicates on dentin (6 individual samples per modification).
Seeding was performed in α-MEM containing 10% heat-inactivated FCS, 100 U/ml penicil-
lin, 100 μg/ml streptomycin und 2 mM glutamine. One day after initial adherence of the
monocytes, medium was changed into α-MEM containing 5% heat-inactivated FCS, 5%
human A/B serum (Sigma), 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine
and 25 ng/ml M-CSF (Peprotech). After two days of cultivation, cells were additionally supple-
mented with 50 ng/mL RANKL (Peprotech). In the case of indirect cultivation extracts of the
different cement modifications were added. Medium was changed twice weekly. After 16 days
of cultivation, cell seeded cement and dentine discs were washed twice with PBS and frozen at
-80˚C for further biochemical analysis. Some cement samples were fixed with 4% of neutral
buffered formaldehyde for microscopy.
Confocal laser scanning microscopy
Actin cytoskeleton and nuclei of the cells were stained by AlexaFluor 4881 phalloidin and
DAPI (both from Invitrogen), respectively, as described previously [18]. Imaging was per-
formed using a Zeiss LSM confocal scanning laser microscope, located in the Core Facility Cel-
lular Imaging (CFCI) of Technische Universität Dresden.
TRAP staining
TRAP staining was performed for 10 min at 37˚C by immersion of fixed samples in 0.3 mg/ml
Fast Red Violet LB (Sigma) in 0.05 M sodium acetate (Sigma), 0.05 M acetic acid (Sigma), 0.03
M sodium tartrate (Roth), 0.1 mg/ml naphthol AS-MX phosphate disodium salt (Sigma) and
0.1% Triton X100 (Sigma). After washing with PBS, cell nuclei were stained for 10 min using
Mayers Haemalaun solution (AppliChem) followed by rinsing in tap water. Stained samples
were imaged using a Keyence BZ-9000 (Biorevo).
Activity quantification of osteoclast-specific enzymes
Prior to determination of intracellular enzyme activities samples were thawed, cells were lysed
using 1% Triton X-100 in PBS for 50 min on ice with a 10 min treatment in an ultrasonic bath.
Cell lysates were collected in 0.5 ml tubes and subjected to the different assays.
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TRAP activity. 10 μl of cell lysate was mixed with 50 μl TRAP reaction buffer (2.5 mM
naphthol-ASBI-phosphateHCl (Sigma) in 100 mM sodium acetate and 50 mM disodium tar-
trate pH 6.1) and incubated at 37˚C for 30 min. Finally, 150 μl of 0.1 M NaOH was added to
stop the enzymatic reaction. The intensity of fluorescence was measured with a multifunction
microplate reader at an excitation and emission wavelength of 405/520 nm. Calibrator solu-
tions with different TRAP concentrations (0.6 to 12 U/L) taken from a commercially available
ELISA kit (BoneTRAP, Medac) were used to correlate the fluorescence intensity with TRAP
activity.
CA II activity. 50 μl of cell lysate were mixed with CA II reaction buffer containing 12.5
mM TRIS pH 7.5, 75 mM NaCl and 2 mM 4-nitrophenylacetate (50 μl, Sigma). Absorbance
was monitored at 400 nm for 5 min. Conversion to 4-nitrophenol was calculated from the
slope of the absorbance plot using a calibration line from different dilutions of 1 mM 4-nitro-
phenol (Sigma).
CTSK activity. 10 μl of cell lysate were diluted with lysis buffer to a final volume of 50 μl
and 50 μl of substrate solution (0.1 mM Z-LR-AMC (Enzo Life Sciences) in 0.1 M sodium ace-
tate buffer containing 4 mM EDTA and 4 mM DTT at pH 5.5) were added. After incubation
for 30 min at 37˚C the fluorescence intensity was measured at an excitation/emission wave-
length of 365/440 nm. The amount of released aminomethylcoumarin (AMC) was quantified
with a calibration line.
Analysis of resorption pits on dentin discs
After performing cell lysis as described above, dentin samples were washed with deionized
water and dried at 60˚C for 12 hours. After drying, samples were mounted on stubs, sputter
coated with gold and imaged using a Philips XL 30/ESEM with FEG (field emission gun), oper-
ated in SEM mode. Six independent SEM images per sample with 500x magnification were
used for the calculation of resorption area applying the open source software Fiji [19]. The
combined area of resorption pits and trails was calculated after manually marking with the
oval selection tool.
Gene expression of osteoclast markers
RNA was extracted from six cell- seeded cement samples of each sample group and for cells of
two donors using the peqGOLD MicroSpin Total RNA Kit (Peqlab) according to the manufac-
turer’s instructions. During the RNA isolation procedure, cell lysates of three samples of each
sample group were pooled to obtain a sufficient amount of RNA for further analysis. 100 ng of
total RNA were transcribed into cDNA in a 20 μL reaction mixture containing 200 U of super-
script II reverse transcriptase (Invitrogen), 0.5 mM dNTPs (Invitrogen), 12.5 ng/μL random
hexamers (Eurofins MWG Operon, Germany) and 40 U of RNase inhibitor RNase OUT (Invi-
trogen). 1 μl cDNA in 20 μL reaction mixtures containing specific primer pairs was used for
amplification in PCR analysis to detect transcripts of TRAP (forward TTC TAC CGC CTG CAC
TTC AA; reverse AGC TGA TCT CCA CAT AGG CA), CA II (forward TAA CTT CGA TCC TCG
TGG CCT C; reverse GCC AGT TGT CCA CCA TCA GTT C), CTSK (forward GAT ACT GGA CAC
CCA CTG GGA, reverse CAT TCT CAG ACA CAC AAT CCA C) and vitronectin receptor (VNR)
(forward AAG TTG GGA GAT TAG ACA GAG G, reverse CTT TCT TGT TCT TCT TGA GGT GG).
GAPDH was used as housekeeping gene. Primer sequences were designed with “PCR Primer
Design” (Eurofins). All synthesis steps were carried out in a thermocycler (Mastercycler1pro,
Eppendorf). PCR products were visualised in 2% agarose gels (Ultra PureTMAgarose, Invitro-
gen). Intensity of the gel bands was analysed with Image J 1.44p (freeware, NIH, U.S.A.) and
related to the intensity of GAPDH band.
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Release of inflammatory cytokines
PBMC were isolated from buffy coats of three different donors as described in the chapter
“osteoclast formation”. Cement samples (3 mm diameter, 4 mm height, sterilized by γ-irradia-
tion and pre-incubated in 2 ml of α-MEM containing 10% heat-inactivated FCS overnight)
were seeded with 1106 PBMC per sample in 12 well plates, precoated with BSA to prevent
protein binding to the dish. Four samples were prepared per donor and cement modification
(reference, Cu10, Co10, Cr10 and Cr50). Furthermore, three samples per donor were seeded
on TCPS without addition of cements (control) and three samples per donor were seeded on
TCPS and stimulated with 1 μg/ml lipopolysaccharide (LPS) (positive control). All samples
were cultivated in 2 ml α-MEM containing 10% heat-inactivated FCS. Supernatants were col-
lected after 16 h of incubation and frozen at -20˚C until further analysis. The concentrations of
tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) were determined using
human TNF-α TMB ELISA development kit and human IL-1β TMB ELISA development kit
(both from Peprotech) according to manufacturer‘s instructions.
Statistics
For the measurement of osteoclast-specific enzyme activities and gene expression analysis
one-way analysis of variance (ANOVA) was used to evaluate statistical significance at a level of
p<0.05. For the resorbed area two-way ANOVA with cement modification and donor as
parameters was used to evaluate statistical significance at a level of p<0.05. Post-hoc analysis
was performed in all cases to determine multiple comparisons using the Tukey method (Ori-
gin 9.1, OriginLab).
Results
Osteoclast formation on the cements
After 16 days of cultivation osteoclast-like cells with actin rings were detected on the reference
cement and on the Co10, Cr10 and Cr50 modifications (Fig 1). Cells and actin rings were
smaller on Co10 cement compared to reference and the Cr3+ doped cements. Only in some
cases (PBMC of two donors) scattered cells were visible on the surface of Cu10 cements. When
the cement discs were seeded with cells of three other donors, no cells were detectable on the
surface of Cu10 cements.
Osteoclast-specific enzyme activities
After 16 days of cultivation activity of TRAP, CAII and CTSK was detected on all cement modi-
fications except Cu10 (Fig 2). There were no significant differences (p<0.05) between TRAP
activities of the different cement modifications Co10, Cr10, Cr50 and reference cement. CA II
activity on the reference cement was significantly (p<0.05) higher compared to all metal ion
containing modifications. CTSK activity on Cr50 cement was significantly higher compared to
all other modifications and to the reference. Generally enzyme activities showed high variations,
especially between cells of different donors. DNA content on Cu10 and Co10 cements was sig-
nificantly (p<0.05) lower compared to the other cement modifications and the reference.
Ion release from cements during cultivation
The concentration of Cu2+, Co2+ and Cr3+ ions in the cell culture medium was determined
after 1 day and during the last three days (d13-d16) of osteoclast cultivation by ICP-MS. For
Co2+ and Cu2+ the initial release was up to tenfold higher compared to the release between d13
and d16 of cultivation. In contrast very low amounts of Cr3+ were released by the cements
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samples but the Cr3+ concentration was higher after 16 days of cultivation compared to the ini-
tial release after 1 day (Table 1).
In a second experiment the concentration of Ca2+, PO4
3- and Cr3+ released from Cr10 and
Cr50 and reference cement samples in the absence of cells (passive ion release) and during cul-
tivation of PBMC/osteoclasts (active release) was analysed by ICP-MS (Fig 3). Again an
increase of Cr3+ concentration during cell cultivation was detected. Interestingly, the Cr3+
release was considerably higher in the absence of cells (Fig 3G and 3H).
The release of Ca2+ from the reference cement showed a steady increase over cultivation
time in the presence of cells. In contrast Ca2+ concentration in the medium dropped below
basal level from day 9 in the absence of cells (Fig 3D). Cr10 and Cr50 cements released lower
Ca2+ amounts compared to the reference in the presence of cells. Interestingly, the Cr10 modi-
fication also released Ca2+ in the absence of cells (Fig 3E).
Phosphate release of the reference cement increased during incubation in the absence of
cells, while it dropped below basal medium concentration in the presence of osteoclasts (Fig
3A). Cr10 and Cr50 cements released lower phosphate amounts compared to the reference in
the absence of cells. In the presence of osteoclasts the phosphate content dropped, but not as
drastically as during cultivation of osteoclasts on the reference cement (Fig 3B and 3C).
Gene expression of osteoclast-specific markers
Gene expression of typical osteoclast-related genes TRAP, CAII, VNR and CTSK was detected
on the reference cement and the Co10, Cr10 and Cr50 modifications after 16 days of osteoclast
Fig 1. Osteoclast formation on the surface of the cements. CLSM images of osteoclasts differentiated from human PBMC
for 16 days under stimulation with M-CSF and RANKL on brushite cement as reference, and on Cu10, Co10, Cr10 and Cr50
modifications. Nuclei are stained in blue, and actin cytoskeleton is stained in green. Scale bars represent 50 μm.
https://doi.org/10.1371/journal.pone.0182109.g001
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cultivation. In the case of Cu10 cements, isolated RNA amounts were not sufficient for analy-
sis. TRAP and CAII expression did not show significant differences between the cement modi-
fications (Fig 4A and 4B). In contrast, the expression of VNR was higher in all modified
cements compared to the reference however the differences were only statistically significant
for the Co10 modification (Fig 4C). CTSK expression of osteoclasts cultured on the Cr50 mod-
ification was significantly increased compared to the reference and Co10 and Cr10 modifica-
tions (Fig 4D).
Release of inflammatory cytokines
Concentrations of TNF-α in the LPS stimulated samples after 16 h of incubation were 622 ± 77
pg/ml; 742 ± 98 pg/ml and 1055 ± 251 pg/ml for the samples of three different PBMC donors.
TNF-α concentration in control samples and also in the supernatants of the different cement
samples was below 23,44 pg/ml which was the detection limit of the applied ELISA kit.
Fig 2. DNA content, TRAP, CAII and CTSK activities of osteoclasts after direct cultivation on CPC.
Osteoclasts were differentiated for 16 days directly on the surface of the CPC (reference) and Cu10, Co10,
Cr10 and Cr50 modifications. PBMC of 5–9 donors were included into the analysis. Each box shows the 25th
to 75th percentile of the measured data. Squares (□) represent mean values, horizontal bars inside the
box show the median value, while upper and lower bars indicate the upper and lower values within 1.5 times
the inter-quartile range from the upper and lower quartile. Individual data points are shown on the left side of
each box. * statistically significant differences (p<0.05) to all other sample types.
https://doi.org/10.1371/journal.pone.0182109.g002
Table 1. Release of metal ions from doped calcium phosphate cements. Cell culture supernatants from cement samples (6mm diameter, 1 mm height)
during direct cultivation with human PBMC/osteoclasts were analysed by ICP-MS.
cement modification metal ions released (mM)
after 1 day
metal ions released between d13 and d16 (mM)
Cu10 0,305 ± 0,023 0,027 ± 0,003
Co10 0,247 ± 0,026 0,027 ± 0,003
Cr10 0,00102 ± 0,00002 0,00180 ± 0,00012
Cr50 0,00551 ± 0,00060 0,01057 ± 0,00062
https://doi.org/10.1371/journal.pone.0182109.t001
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Concentrations of IL-1β in the LPS stimulated samples after 16 h of incubation were 125 ±
36 pg/ml; 116 ± 13 pg/ml and 88 ± 35 pg/ml for the samples of three different PBMC donors.
IL-1β concentration in control samples and also in the supernatants of the different cement
samples was below 5,9 pg/ml which was the detection limit of the applied ELISA kit.
Indirect cultivation with cement extracts for resorption analysis
Since direct analysis of resorbed area was not possible on the examined cements because of
their rough surface, PBMC were cultivated on dentine discs in the presence of extracts of the
different cement modifications to analyse resorption activity. Extracts of Cu10 and Co10
cements were diluted with cell culture medium to avoid cytotoxic effects of Co2+ and Cu2+ (see
materials and methods). Analysis of DNA content after 16 days of cultivation revealed donor-
specific variations but no significant cell reduction compared to the control, indicating no
cytotoxic effects of the applied cement extracts in the respective dilution (S1 Fig). Nevertheless,
after 16 days of cultivation no resorption pits were detected on samples which were cultivated
in the presence of Cu10 extracts. In contrast all other samples showed resorption pits (Fig 5).
Resorbed area in the presence of unmodified cement extract was reduced in comparison to the
control, however this effect was not statistically significant. Resorbed area in the presence of
Co10, Cr10 and Cr50 extracts was significantly elevated compared to both reference and con-
trol (p<0.5) (Fig 6).
Fig 3. Release of PO43-, Ca2+ (d-f) and Cr3+ from Cr3+ doped CPC. ICP-MS was used to quantify the release of
PO4
3-(a-c) Ca2+ (d-f) and Cr3+ (g, h) into cell culture medium in the absence of cells (passive) and during cultivation
of PBMC/osteoclasts (active). For passive release 6 samples of the respective cement modification were incubated
in each 200 μl of cell culture medium. For active release PBMC of three different donors were seeded on 18 cement
samples per modification in total (6 samples per donor). Medium of all samples was changed at days 1, 2, 6, 9, 13
and 16. Three medium samples per donor, modification and cultivation day were pooled to get enough volume for
analysis. Cell culture medium concentration of Ca2+and PO4
3- was subtracted as blank.
https://doi.org/10.1371/journal.pone.0182109.g003
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Additionally, PBMC were cultivated with cement extracts on TCPS under osteoclastic stim-
ulation. After 16 days of cultivation, TRAP staining revealed the formation of TRAP positive
multinucleated osteoclasts in all samples (Fig 7). Cells which were cultivated without cement
extracts (control) and in the presence of diluted extracts from Co10 cements showed a higher
number of osteoclasts and higher osteoclast size compared to all other samples. In contrast,
osteoclast size and number was reduced in the presence of extracts from the reference cement,
Cr10 and Cr50 cement and diluted Cu10 cements.
Discussion
Bioactive metal ions are an inexpensive and stable alternative to growth factors for the modifi-
cation of calcium phosphate based biomaterials. To evaluate the possible impact of Cu2+, Co2+
and Cr3+ ions on healing of bone defects, in vitro investigations on the impact of the modified
materials on angiogenesis and osteogenesis, but also on osteoclast-mediated resorption are
necessary. The aim of the present study was to analyse the impact of Cu2+, Co2+ and Cr3+ mod-
ification of calcium phosphate cements on osteoclast formation and activity. Osteoclast forma-
tion was observed on all cement modifications except Cu10 modification after 16 days of
cultivation. Measurement of DNA content revealed very low cell number on Cu10 cements, so
the failed osteoclast formation in these experiments was presumably caused by cytotoxic effects
due to the burst release of Cu2+. The released concentration of Cu2+ after 1 day of incubation
was 305 ± 23 μM, which is far above the cytotoxic threshold for PBMC/osteoclasts of approxi-
mately 30 μM (S2 Fig). Consequently, besides the low DNA content no activity of the osteo-
clast-specific enzymes TRAP, CAII and CTSK was detected for the Cu10 cement modification.
Fig 4. Gene expression analysis. Expression of osteoclast-specific genes was analysed after 16 days of
osteoclast cultivation on CPC (reference) and Co10, Cr10 and Cr50 modifications A) TRAP, B) CAII, C) VNR
and D) CTSK. Six cement samples of each modification were seeded with cells and lysates of three samples
were pooled to obtain two data points per modification and donor. Cells of two donors were included into the
analysis. PCR products were visualized in agarose gels; the intensities of the gel bands was analysed using
the open source software Fiji and related to the intensity of the GAPDH bands. Furthermore, the band
intensities of the reference cement were set to 1 for each individual donor. * statistically significant differences
(p<0.05) to the reference.
https://doi.org/10.1371/journal.pone.0182109.g004
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To further evaluate the impact of Cu10 modification on resorption and to obtain an impres-
sion whether fabrication of Cu2+ doped cements with lower Cu2+ doses would be beneficial for
application as bone graft material, extracts for the indirect resorption assay on dentin slices
were diluted to a final Cu2+ concentration of 17.8 μM. Nevertheless, cultivation of PBMC
under osteoclastic stimulation on dentin in the presence of the Cu2+ containing extracts
revealed no resorption of dentin despite the survival of the cells which was demonstrated by
DNA content of the samples which was in a similar range compared to all other examined
samples (S1 Fig). Furthermore, TRAP staining on TCPS indicated the formation of TRAP pos-
itive multinucleated cells in the presence of diluted Cu10 extracts. We therefore postulate, that
Fig 5. SEM analysis of resorption pits. Representative SEM images of resorption pits after 16 days
cultivation of PBMC derived human osteoclasts on dentine slices in the presence of different cement extracts
(reference = non-modified CPC) compared to cell culture medium (control). A, B, C represent cells of three
different PBMC donors, scale bar represents 500 μm.
https://doi.org/10.1371/journal.pone.0182109.g005
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Cu2+, at least when released from a calcium phosphate cement rather inhibits the resorption
activity of osteoclasts than their formation. Similar results were obtained by Yang and co-
workers, who cultivated primary rabbit osteoclasts on calcium phosphate films with incorpo-
rated Cu2+ [15]. While the osteoclast number was not significantly affected by Cu2+ containing
calcium phosphate films and no cytotoxic effects were revealed by determination of lactate
dehydrogenase activity in the supernatants, the resorbed area of the calcium phosphate films
Fig 6. Average resorbed area on dentin slices. Osteoclasts were differentiated in the presence of different
cement extracts (reference = non-modified CPC) compared to cell culture medium (control). Image J software
was used to calculate resorbed area of six to eight SEM images with 500 x magnification, A, B, C represent
cells of three different donors.
https://doi.org/10.1371/journal.pone.0182109.g006
Fig 7. TRAP staining. Osteoclasts were differentiated in the presence of different cement extracts
(reference = non-modified CPC) compared to cell culture medium (control) on TCPS for 16 days. TRAP
activity stained in purple, nuclei are counterstained in blue. Scale bars represent 200 μm.
https://doi.org/10.1371/journal.pone.0182109.g007
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significantly decreased with increasing Cu2+ concentration in the films. However, Cu2+ release
into cell culture medium was not quantified in this study which makes it harder to compare
these data. A historic investigation of Wilson and coworkers likewise revealed an inhibiting
effect of Cu2+ on bone resorption [20]. It was shown, that 10 μM Cu2+ decreased resorption
to 33% of control samples measured by release of 45Ca. Cu2+ doped brushite cement was
included into our study since Cu2+ doping of calcium phosphate ceramics was shown to accel-
erate and guide angiogenesis [6]. The inhibited resorption of Cu2+ containing calcium phos-
phate cements might be beneficial for patients which show a impaired balance between
osteogenesis and resorption, e.g. during osteoporosis. Since the presence of viable osteoclasts
is important for cross-talk of bone cells during remodeling, Cu2+ doped cements should con-
tain in future considerably less Cu2+ than the Cu10 cement used in the present study.
Co10 cements showed a burst release of Co2+ with 247 ± 26 μM Co2+ present in the super-
natant after 1 day of incubation in cell culture medium. We did not specifically analyse the
cytotoxic threshold of Co2+ for PBMC/osteoclasts, but previous investigations have shown a
slight cyctotoxic effect of 100 μM Co2+ and a strong cytotoxic effect of 500 μM Co2+ (S3 Fig).
The observed burst release of Co2+ was also previously detected by examining brushite
cements of different dimensions [7] and also described during release of Co2+ from calcium
phosphate coatings [21]. The relatively high initial Co2+ concentration might be the reason for
the drastically reduced DNA content of cell lysates after 16 days of cultivation of PBMC/osteo-
clasts on Co10 cements compared to the reference cement. Nevertheless osteoclasts, visible as
multinucleated cells with actin rings were detected also on the surface of Co10 cements. Fur-
thermore TRAP activity of the cell lysates after cultivation of osteoclasts on Co10 was not sig-
nificantly different to TRAP activity in the presence of the reference cement and the Cr3+
modified cements. TRAP activity has been established as a marker for osteoclast number at
least on TCPS and bone [22,23]. In a previous study we have comprehensively investigated the
activity of osteoclast specific enzymes TRAP, carbonic anhydrase II (CA II) and cathepsin K
for human osteoclasts on different materials [17]. A correlation between intracellular TRAP
and CAII activity and resorbed area was demonstrated for hydroxyapatite forming calcium
phosphate bone cements. Intracellular TRAP activity on Co10 cement therefore suggests an
active resorption of the material despite low cell number. Gene expression of vitronectin
receptor, a late stage osteoclast differentiation marker was significantly increased for osteo-
clasts on Co10 cements further evidencing a promoting effect of Co10 cement on osteoclasto-
genesis. Indirect resorption assays on dentine slices in the presence of Co10 cement extracts
resulted in the highest resorbed area compared to all other cement extracts. These results sug-
gest a clear resorption promoting effect of Co2+ especially in concentrations around 20 μM
and in the presence of calcium phosphate bone cement. Similar results were obtained after cul-
tivation of bone marrow derived mouse osteoclasts on calcium phosphate coatings doped with
Co2+ [21]. TRAP activity and total resorbed area were elevated in the presence of Co2+ while
osteoclast number was only increased at very low Co2+ concentrations (0.1 μM when added to
the medium and 1 μM incorporated into the calcium phosphate layer). Two more studies ana-
lysed the effect of Co2+ without additional biomaterials on human PBMC derived osteoclasts.
Andrews and co-workers [14] report only a mild stimulatory effect of Co2+ on developing oste-
oclast number and resorption activity at very low concentrations (around 0.01 μM). Higher
Co2+ concentrations (10–200 μM) decreased both osteoclast number and resorbed area for
developing and mature osteoclasts. In contrast Mabilleau et al [24] report a significant increase
of both number and size of multinucleated TRAP positive osteoclasts after cultivation of
PBMC derived human osteoclasts in the presence of 100 μM Co2+. Due to the significantly
increased osteoclast number at 100 μM Co2+, the resorbed area per osteoclast was strongly
decreased. Evidently the effect of Co2+ on osteoclastogenesis and resorption depends on
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several factors like donor variability of the primary cells, presence (or absence) of other ions
like Ca2+ and PO4
3- in combination with calcium phosphate based materials and variations of
concentration during Co2+ release. Beside the partly contradicting data from the literature, the
complex effect of Co2+ also becomes obvious in the present study: Co10 cements seem to show
no enhanced resorption compared to non-modified calcium phosphate cements (as deduced
from TRAP and CAII activity), but osteoclast cultures on dentine with diluted extracts from
Co10 cements showed a considerably increased resorbed area, which was confirmed indepen-
dently by cells of three different donors. Nevertheless the modification of brushite cements
with Co2+ for better remodeling of bone defects seems to be not promising because of its cyto-
toxic effects towards osteoblast progenitor cells as shown in our previous study [7]. Further-
more, Co2+ incorporated β-TCP has been shown to switch the macrophage phenotype to M1
which is related to the release of pro-inflammatory cytokines [25]. However, in the present
study PBMC cultured in the presence of Co2+ doped cements did not show elevated levels of
the pro-inflammatory cytokines TNF-α and IL-1β.
The incorporation of Cr3+ into brushite forming cements resulted in the formation of
barely soluble chrome phosphates which was accompanied by release of very low concentra-
tions of Cr3+ compared to Co2+ and Cu2+ [7]. In the present study the low and steady release
of Cr3+ was confirmed. Interestingly and unexpectedly the Cr3+ release in the presence of
PBMC/osteoclasts was lower compared to the passive release in the absence of cells. Possibly,
Cr3+ was endocytosed by the cells as shown previously for PBMC derived human osteoclasts
[26]. Osteoclast formation on the Cr3+ doped cements was similar to the reference and to the
Co2+ doped modification. Also the activity of osteoclast-specific enzymes was comparable to
the reference and the Co2+ doped modification. However, the activity of CTSK was signifi-
cantly increased for osteoclasts on Cr50 compared to the reference and both Cr10 and Co10.
Coincidently, the gene expression of CTSK was significantly higher on Cr50 compared to all
other modifications. Taking a look to the results of the indirect resorption tests it becomes
obvious that, at least for two of the three examined donors, the resorbed area was considerably
increased with Cr50 extracts compared to the reference and control. Due to the very low Cr3+
concentration compared to Co2+ and Cu2+ (highest values for Cr3+ release in the presence
of osteoclasts was ~0.7 μM for Cr10 and ~1 μM for Cr50 cements) no cytotoxic effects are
expected. Even concentrations of 1mM Cr3+ did not provoke any cytotoxic signs in PBMC/
osteoclasts (S4 Fig). Cr3+ concentration in the synovial fluid of patients with metal on metal
prosthetic implants was found to be up to 25 μM [27]. At those and higher Cr3+ concentrations
decreased osteoclast numbers (100 μM Cr3+) [24] and an inhibited osteoclastic resorption
(200 μM Cr3+) [14] were detected. These Cr3+ concentrations are at least 2–3 magnitudes
higher than the released Cr3+ concentration from the calcium phosphate cements in our study.
Very low Cr3+ concentrations are reported to positively influence osteoclastogenesis and
resorption. Andrews et al. reported an increased osteoclast number as well as an increased
resorption after treatment of PBMC derived osteoclasts with 0,1 μM Cr3+ [14]. The possibly
increased resorption of the Cr3+ doped cements could be caused not only by the released Cr3+
ions but also by the changed morphology of the cement matrix and the altered cement compo-
sition showing a significant amount of monetite as additional calcium phosphate phase in the
case of Cr50 cements [7]. It has been demonstrated before that both brushite and monetite are
actively resorbed by osteoclasts [28,29]. Furthermore, incorporation of Cr3+ into the calcium
phosphate cement caused changes in the release/uptake of Ca2+ and PO4
3-. The unmodified
cement decreased the Ca2+ content of the incubation medium probably due to re-precipitation
of hydroxyapatite when incubated without cells. Incubation in the presence of osteoclasts lead
as anticipated to an ascending release of additional Ca2+ into the cell culture medium. Ca2+
release is commonly accepted as a marker for osteoclastic resorption of bone [30] and calcium
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phosphate bone cements [28,29,31]. Doping of brushite cements with Cr3+ prevented the
uptake of Ca2+ and the release of PO4
3- suggesting a changed dissolution behavior of the
cement modification. Ca2+ release from Cr3+ doped cements in the presence of osteoclasts was
lower compared to the release from the reference cement indicating a lower resorption of the
Cr3+ doped cement on the first glance. Nevertheless, this is in contrast to the results of osteo-
clast enzyme activities and gene expression of osteoclast markers on Cr3+ modified cements
and to the indirect experiment with Cr10 and Cr50 cement extracts, suggesting higher resorp-
tion compared to the reference cement. We propose that Ca2+ release is no reliable resorption
marker in the case of Cr3+ doped cements, since the dissolution/precipitation behavior of the
brushite cement is changed by the Cr3+ modification.
The present study together with our previous study on osteoprogenitor cells revealed high
cytocompatibility of Cr3+ doped brushite cements. A further crucial aspect for the evaluation
of innovative biomaterials is the immunogenicity of the material, since inflammatory reactions
may result in implant failure. Therefore, the release of the pro-inflammatory cytokines TNF-α
and IL-1β was analysed for PBMC cultivated in the presence of metal ion doped cements and
the reference cement. While LPS stimulated PBMC showed considerably increased cytokine
levels, which were similar to already published data [32] the concentration of both TNF-α and
IL-1β in the presence of metal ion doped and undoped brushite cements was below the detec-
tion limit of the assay. It has been shown earlier, that human monocytes (THP-1 cell line) were
not stimulated to release TNF-α in the presence of different calcium phosphates (including
brushite, HA and β-TCP) [33]. The finding that both pure brushite cement and Cr3+ doped
brushite cement did not provoke enhanced release of pro-inflammatory cytokines from PBMC
in vitro suggests high potential of these materials for bone regeneration in vivo.
Conclusions
Cu2+ and Co2+ doping of brushite cements with 10 mmol/ g β-TCP may cause cytotoxic reac-
tions towards osteoclasts and osteoclast progenitors during initial burst release of Cu2+ and
Co2+ respectively. Cements with lower doses Cu2+ might be beneficial for application in bone
regeneration, since Cu2+ at 18 μM completely inhibited resorption (but not osteoclast forma-
tion) which might be beneficial for patients with osteoporosis and therefore an imbalance
between bone formation and resorption. Best results were obtained for brushite cements
doped with different concentrations of Cr3+. Our study revealed an increased osteoclastic
resorption of these cements compared to the non-modified brushite cement and a very low
release of metal ions which diminishes the risk of cytotoxic reactions. Furthermore, Cr3+
doped brushite cements have been shown to increase viability of osteoprogenitor cells in com-
parison to non-modified brushite cement [7]. Therefore Cr3+ doped brushite cements are sug-
gested as promising new material for application in bone regeneration.
Supporting information
S1 Fig. DNA content of PBMC/osteoclasts after 16 days of indirect cultivation with cement
extracts. Osteoclasts were differentiated in the presence of different cement extracts (reference =
non-modified CPC) compared to cell culture medium (control) on TCPS for 16 days. DNA was
quantified from cell lysates (n = 5 per sample group and donor). A, B, C represent cells of three
different donors.
(TIF)
S2 Fig. Cytotoxic threshold for Cu2+. PBMC of two different donors were cultivated under
standard conditions with 25 ng/ml MCSF and 50 ng/ml RANKL under addition of different
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concentrations of Cu2+ as Cu(NO3)23 H2O. After 16 days of cultivation, cells were fixed and
stained for TRAP activity. Scale bars represent 100 μm.
(TIF)
S3 Fig. Cytotoxic threshold for Co2+. PBMC of two different donors were cultivated under
standard conditions with 25 ng/ml MCSF and 50 ng/ml RANKL under addition of different
concentrations of Co2+ as Co(NO3)26 H2O. After 9 days of cultivation, cells were fixed and
stained for TRAP activity. Scale bars represent 100 μm.
(TIF)
S4 Fig. Cytotoxic threshold for Cr3+. PBMC of two different donors were cultivated under
standard conditions with 25 ng/ml MCSF and 50 ng/ml RANKL under addition of different
concentrations of Cr3+ as Cr(NO3)39 H2O. After 9 days of cultivation, cells were fixed and
stained for TRAP activity. Scale bars represent 100 μm.
(TIF)
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